Regenerative Protein Arrays (RPA): Potentially Offering a New Future
Key Points:
The science of regenerative proteins and going beyond PRP/stem cells.
The adherence to strict donor selection process, CGTP guidelines, 3rd party FDA/CLIA lab testing, and cellular filtration process provide the highest level of patient safety.
The very unique regulatory classification of RPA as a “cell factor” provides security and freedom for your clinicians.
360 degree support of your clinicians provides clinical learning, Clinical Advisory Board support, multimedia marketing, and legal/regulatory guidance in a fast-paced environment.
